Allego N.V. Ordinary Shares (ALLGF) Live Share Price, Invest From India

Allego N.V. Ordinary Shares Stock Performance

as on October 24, 2026 at 12:34 am IST

Day's Low
Day's High
$0.03
Day's Price Range
$0.03
$0.00
-2627.27%
Downside
2627.27%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$0.04
$0.00
100.00%
Downside
3536.36%
Upside

Allego N.V. Ordinary Shares share price movements today

Previous Close: $0.00
Open: $0.03
Volume: 100.0
Day's Low - High: $0.03 - $0.03
52 Week Low - High: -

Allego N.V. Ordinary Shares Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Allego N.V. Ordinary Shares Stock Fundamentals & Key Indicators

Check Allego N.V. Ordinary Shares market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

0.00

Return On Equity TTM

-72.03%

Allego N.V. Ordinary Shares stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Allego N.V. Ordinary Shares with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Allego N.V. Ordinary Shares	NA	$-	NA	NA	0.00%	0.00%

Indian Investors' Interest in Allego N.V. Ordinary Shares Stock

Search interest for Allego N.V. Ordinary Shares Stock has increased by 1900% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 24, 2026 to October 24, 2026

Change:1900% versus previous 30 day period

Allego N.V. Ordinary Shares Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024
Total Revenue	10	10	30	54	20	22	38	29	29	48
Gross Profit	3	3	0	7	-2	-4	5	-1	-3	10
Operating Income	-3	-2	-239	-91	-29	-15	-4	-15	-23	-14
EBITDA	-3	-2	-235	-89	-24	-8	1	-12	-27	-12
Interest Expense	-	-	-	-	-	4	8	6	7	7
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	0	0	-355	-95	103	-19	-12	-25	-44	-28
Income Tax Expense	0	-3	0	0	0	0	0	0	0	0
Net Income	0	0	-355	-95	103	-19	-12	-25	-44	-28
Net Profit Margin	2.44%	1.42%	-1152.20%	-173.60%	513.69%	-83.67%	-33.85%	-87.27%	-150.37%	-57.71%

Allego N.V. Ordinary Shares Annual Profit & Loss

All numbers in Millions USD

	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023
Total Revenue	1	291	58	56	27	25	44	89	131	145
Gross Profit	-43	246	0	-15	-87	4	13	13	0	36
Operating Income	-77	211	-34	-61	-152	-36	-32	-327	-304	-71
EBITDA	-	-	-	-	-	-28	-22	-292	-277	-50
Interest Expense	-	-	-	-	-	5	11	15	15	27
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-76	207	-48	-63	-150	-42	-43	-332	-299	-109
Income Tax Expense	-	-	-	-	-	0	0	0	0	0
Net Income	-76	207	-48	-63	-150	-43	-43	-332	-299	-109
Net Profit Margin	-6222.20%	71.11%	-82.34%	-112.10%	-555.16%	-166.93%	-97.76%	-370.46%	-227.62%	-75.56%

Allego N.V. Ordinary Shares Quarterly Cash Flow

All numbers in Millions USD

	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024
Net Income	0	-355	-95	103	-20	-12	-25	-44	-28
Operating Cash Flow	0	-73	-5	-19	-3	-39	14	-22	1
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	0	146	13	-5	36	-2	41	-1	37
Change in Cash	0	94	2	-65	-13	-54	37	-36	15

Allego N.V. Ordinary Shares Annual Cash Flow

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023
Net Income	207	-48	-63	-150	-42	-43	-332	-299	-109
Operating Cash Flow	204	-37	-99	-104	-56	-34	-9	-106	-45
Investing Cash Flow	0	-2	-88	-7	17	-	-	-	-
Financing Cash Flow	121	327	5	-6	90	36	42	256	75
Change in Cash	328	293	-186	-110	20	-13	17	56	-38

About Allego N.V. Ordinary Shares

Alligator Bioscience AB (publ) develops antibody-based pharmaceuticals for cancer treatment. It develops products using its technology platforms, including ALLIGATOR-GOLD, a proprietary human antibody library that contains approximately 60 billion unique antibody fragments; FIND, a molecular evolution technology for optimization of antibodies and other proteins; and bispecific antibody formats for the development of novel dual-action antibodies. The company develops ADC-1013, an immunostimulatory CD40 antibody, which has completed Phase I clinical trial for the treatment of metastatic cancer; ATOR-1015, a tumor-localizing bispecific CTLA-4 and OX40 antibody, which is in Phase I clinical trial for tumor-directed treatment of metastatic cancer; and ATOR-1017, an immunostimulatory antibody, which is in phase I clinical trial that binds to the receptor 4-1BB (CD137) in tumor-specific T cells. Its drug candidates in the preclinical development stage include ALG.APV-527, a bispecific 4-1BB and 5T4 antibody for the treatment of metastatic cancer; and ATOR-1144, a bispecific antibody to treat solid tumors and hematologic cancers. The company, through its subsidiary, Atlas Therapeutics AB, also holds a stake in clinical project Biosynergy (AC101), which is in phase I clinical trial. It has operations in the United States, Sweden, Asia, and internationally. The company has a partnership agreement with Aptevo Therapeutics Inc. for the co-development of ALG.APV-527. Alligator Bioscience AB (publ) was founded in 2001 and is headquartered in Lund, Sweden.

Organisation	Allego N.V. Ordinary Shares
Headquarters	Medicon Village, Lund, Sweden, 223 81
Industry	Miscellaneous
CEO	Dr. Per Norlén

Key Management of Allego N.V. Ordinary Shares

Name	Title
Dr. Per Norlén	Chief Exec. Officer
Ms. Marie Svensson	Chief Financial Officer
Dr. Malin Carlsson	Head of R&D, Exec. VP & COO
Dr. Peter Ellmark Ph.D.	Chief Scientific Officer
Ms. Cecilia Hofvander	Director of Investor Relations & Communications
Dr. Christina Furebring	Sr. VP of Projects
Ms. Gayle M. Mills	Chief Bus. Officer
Dr. Christina Reimer	Chief Medical Officer

FAQs

What is Allego N.V. Ordinary Shares share price today?

Allego N.V. Ordinary Shares share price today is $0.00 as on October 23, 2026 at 7:04 pm IST. Allego N.V. Ordinary Shares share today touched a day high of $0.03 and a low of $0.03.

What is the 52 week high and 52 week low for Allego N.V. Ordinary Shares share?

Allego N.V. Ordinary Shares share touched a 52 week high of $0.04 on April 22, 2026 and a 52 week low of $0.00 on January 7, 2026. Allego N.V. Ordinary Shares stock price today i.e. October 23, 2026 at 7:04 pm IST is trending at $0.00,which is 97.25% down from its 52 week high and Infinity% up from its 52 week low.

How to invest in Allego N.V. Ordinary Shares Stock (ALLGF) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Allego N.V. Ordinary Shares on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Allego N.V. Ordinary Shares Stock (ALLGF) from India?

Indian investors can start investing in Allego N.V. Ordinary Shares (ALLGF) shares with as little as ₹94.94000244140625 or $1 (as of October 24, 2026 at 1:11 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Allego N.V. Ordinary Shares stock (as per the Rupee-Dollar exchange rate as on October 24, 2026 at 1:11 am IST). Based on Allego N.V. Ordinary Shares share’s latest price of $0.00 as on October 23, 2026 at 7:04 pm IST, you will get 9090.9091 shares of Allego N.V. Ordinary Shares. Learn more about fractional shares .